Partnerships and collaborations are core to Monet’s strategy to transform drug discovery and stimulate innovation.

"We want to build partnerships that create  value for all partners and advance treatments for all patients.”

Monet is actively seeking collaborations with bio-pharmaceutical companies who are interested in leveraging the transformational potential of our novel drug discovery technology.   Monet’s technology is versatile and can be applied to a broad spectrum of disease states.    In addition to having access to Monet’s Protein Painting technology, partnering companies will also have access to Monet’s team of experts to collaborate with and develop independent leads.

If you’re interested in collaborating with us, please contact  Contact Chris Girdwood by phone or the email form below.  

The future of drug discovery is here.  Let's start a conversation!